BIODELIVERY SCIENCES INTERNATIONAL INC Uncategorized Contracts & Agreements
47 Contracts & Agreements
- First Amendment to Promotion Letter, dated November 4, 2020, between the Company and Scott Plesha (Filed With SEC on March 11, 2021)
- First Amendment to Offer Letter, dated November 3, 2020, between the Company and Terry Coelho (Filed With SEC on March 11, 2021)
- First Amendment to Offer Letter, dated October 21, 2020, between the Company and James Vollins (Filed With SEC on March 11, 2021)
- Description of the registrant's securities registered pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 11, 2021)
- Description of the registrant's securities registered pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 12, 2020)
- Amendment, dated May 20, 2018, by and among the Company and Broadfin (Filed With SEC on May 21, 2018)
- Agreement, dated May 17, 2018, between the Company and Broadfin Healthcare (Filed With SEC on May 17, 2018)
- RETIREMENTAGREEMENT (Filed With SEC on August 29, 2017)
- FOIA CONFIDENTIAL TREATMENT REQUEST BY BIODELIVERY SCIENCES INTERNATIONAL, INC. IRS EMPLOYER IDENTIFICATION NUMBER ###-###-#### (Filed With SEC on March 16, 2017)
- FOIA CONFIDENTIAL TREATMENT REQUEST BY BIODELIVERY SCIENCES INTERNATIONAL, INC. IRS EMPLOYER IDENTIFICATION NUMBER ###-###-#### (Filed With SEC on February 27, 2017)
- Confidential Treatment Requested by BioDelivery Sciences International, Inc. IRS Employer Identification No. 35-208985 Confidential treatment requested with respect to certain... (Filed With SEC on June 4, 2015)
- Confidential Treatment Requested by BioDelivery Sciences International, Inc. IRS Employer Identification No. 35-208985 Confidential treatment requested with respect to certain... (Filed With SEC on March 16, 2015)
- 801 Corporate Center Drive, Suite 210, Raleigh, North Carolina 27607 Tel ###-###-#### Fax ###-###-#### www.biodeliverysciences.com Page1 of 3 (Filed With SEC on October 23, 2013)
- Confidential Treatment Requested by BioDelivery Sciences International, Inc. IRS Employer Identification No. 35-208985 Confidential treatment requested with respect to certain... (Filed With SEC on September 19, 2012)
- Table of Contents (Filed With SEC on May 15, 2009)
- MASTER CLINICAL DEVELOPMENTAGREEMENT between BIODELIVERY SCIENCES INTERNATIONAL Raleigh, NC 27607 and PREMIER RESEARCH INTERNATIONAL LLC (Filed With SEC on May 15, 2009)
- AMENDMENT CONSENT (Filed With SEC on January 6, 2009)
- AMENDMENT CONSENT (Filed With SEC on January 6, 2009)
- CONSENT AGREEMENT (Filed With SEC on January 6, 2009)
- ALLONGE (Filed With SEC on September 10, 2007)
- CDC IV, LLC 47 HULFISH STREET, SUITE 310 (Filed With SEC on September 10, 2007)
- [Signature page to follow.] (Filed With SEC on September 10, 2007)
- [Signature page to follow.] (Filed With SEC on September 10, 2007)
- HYPOTHECATION AGREEMENT (Filed With SEC on September 10, 2007)
- DISPUTE RESOLUTION AGREEMENT (Filed With SEC on September 10, 2007)
- SUBLICENSING CONSENT AND AMENDMENT (Filed With SEC on September 10, 2007)
- SECOND AMENDMENT AGREEMENT (Filed With SEC on September 10, 2007)
- SUBLICENSING CONSENT (Filed With SEC on September 10, 2007)
- DISPUTE RESOLUTION AGREEMENT (Filed With SEC on March 16, 2007)
- CERTIFICATE OF DESIGNATIONS, PREFERENCES AND RIGHTS OF (Filed With SEC on February 23, 2007)
- NOTICE OF BREACH AND DEMAND FOR DISPUTE RESOLUTION (Filed With SEC on August 31, 2006)
- SUBLICENSING CONSENT AND AMENDMENT (Filed With SEC on August 9, 2006)
- SUBLICENSING CONSENT (Filed With SEC on August 9, 2006)
- FIRST AMENDMENT AGREEMENT (Filed With SEC on August 9, 2006)
- SECOND AMENDMENT AGREEMENT (Filed With SEC on August 9, 2006)
- CDC IV, LLC 47 HULFISH STREET, SUITE 310 (Filed With SEC on August 9, 2006)
- INTRODUCTORY STATEMENT (Filed With SEC on May 22, 2006)
- INTRODUCTORY STATEMENT (Filed With SEC on May 22, 2006)
- SECOND AMENDMENT (Filed With SEC on January 3, 2006)
- SECOND AMENDMENT (Filed With SEC on January 3, 2006)
